February 19, 2025

Late-Window Alteplase in Acute Ischemic Stroke

"We believe these findings mean more people may return to normal or near-normal lives after a stroke, even if they receive treatment later than originally thought beneficial."

Conexiant

February 18, 2025

Telomere Length May Signal Brain Disease Risk

Compared to those with longer telomeres, individuals with the shortest telomeres demonstrated an 8% higher risk of stroke, a 19% higher risk of dementia, and a 14% higher risk of late-life depression.

Conexiant

February 12, 2025

Can Skin Patches Ease Prostate Therapy?

A phase 2 trial presents promising findings on the effectiveness of transdermal estradiol patches in delivering part of the androgen deprivation therapy for prostate cancer patients, showing potential in reducing adverse effects.

Reuters

February 12, 2025

Fluoroquinolones vs Amoxicillin: Anaphylaxis Risk

Moxifloxacin carries the highest anaphylaxis risk among fluoroquinolones, while the entire drug class shows a lower risk than amoxicillin, Penn State researchers reported.

Conexiant

February 12, 2025

Obinutuzumab Boosts Lupus Nephritis Treatment Success

Phase 3 trial shows adding obinutuzumab to standard lupus nephritis therapy improved complete renal response rates by 13.4 percentage points over placebo, though serious infection risks increased.

Conexiant

February 10, 2025

ADA to hold standards meetings in March

The ADA Standards Program will hold multiple meetings March 10-12 in New York City to discuss dental standards on a variety of topics.

ADA News

February 07, 2025

24-Month Study Shows Ritlecitinib Efficacy in Alopecia

73.5% of patients achieved a SALT score ≤ 20 after 24 months of ritlecitinib treatment, according to new phase III findings.

Conexiant

February 06, 2025

Pediatric Stroke Survivors Show Higher Mental Health Risks

New research reveals children who survive strokes face increased rates of anxiety, depression, and physical symptoms, with age 9 identified as a critical period for mental health challenges, according to findings presented at the 2025 International Stroke Conference.

Conexiant

February 03, 2025

Beta Blocker May Shield Women From Migraine-Linked Strokes

New research shows propranolol, a commonly used blood pressure and migraine medication, may cut ischemic stroke risk by up to 52% in women with migraines—particularly those without aura—while showing no protective effect in men.

Conexiant